5-Amino-1MQ is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
5-Amino-1MQ is being researched for weight loss applications. Selectively inhibits the NNMT enzyme, which normally degrades nicotinamide and prevents NAD+ synthesis. By blocking NNMT, it frees nicotinamide for NAD+ production via the salvage pathway and activate. Common dosages for this use range from 150-500 mcg subcutaneous, 50-100 mg oral once to twice daily.
Can 5-Amino-1MQ Help With Weight Loss?
5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is being researched for weight loss applications based on its mechanism as a Small molecule NNMT inhibitor.
Selectively inhibits the NNMT enzyme, which normally degrades nicotinamide and prevents NAD+ synthesis. By blocking NNMT, it frees nicotinamide for NAD+ production via the salvage pathway and activates SIRT1 longevity pathways. Also stimulates AMP-activated protein kinase (AMPK) in adipocytes and myocytes, promoting mitochondrial biogenesis and fat oxidation.
What Does the Research Show for 5-Amino-1MQ and Weight Loss?
Improved grip strength by ~60% when combined with exercise in aged mice. Increased endurance and reduced recovery time in animal models. Preclinical evidence shows protection against diet-induced weight gain. No human clinical trials completed.
The relevance to weight loss specifically comes from 5-Amino-1MQ's effects on fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects.
What Protocol Is Used for Weight Loss?
For weight loss applications, the standard 5-Amino-1MQ protocol is 150-500 mcg subcutaneous, 50-100 mg oral administered once to twice daily via subcutaneous injection or oral for 4-12 weeks.
Some researchers adjust dosing based on the specific weight loss application — see our 5-Amino-1MQ dosage guide for full protocol details.
Can Stacking Improve Weight Loss Results?
Pairs well with NAD+ precursors (NMN, NR) for synergistic metabolic enhancement, and with MOTS-C for comprehensive mitochondrial optimization.
What Side Effects Apply to Weight Loss Use?
Good tolerability in preclinical data. No major adverse events reported. Limited human safety data — long-term effects in humans unknown.
Side effects are generally consistent regardless of the specific application. See our 5-Amino-1MQ side effects guide for details.
Calculate Your 5-Amino-1MQ Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for 5-Amino-1MQ.
Open Calculator →Bottom Line: 5-Amino-1MQ for Weight Loss
5-Amino-1MQ shows preliminary research potential for weight loss. Standard protocols (150-500 mcg subcutaneous, 50-100 mg oral, once to twice daily, 4-12 weeks) apply.
Source from COA-tested vendors and maintain consistent dosing for the full cycle duration.
Complete Guide
5-Amino-1MQ : Benefits, Dosage, Side Effects & Research
Related Reading
- 5-Amino-1MQ Dosage Guide
- 5-Amino-1MQ Benefits
- 5-Amino-1MQ Side Effects
- 5-Amino-1MQ Stacking Guide
- 5-Amino-1MQ Cycle Guide
- 5-Amino-1MQ Research
Research-Grade Sourcing
If you're going to research 5-Amino-1MQ, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is 5-Amino-1MQ?
5-Amino-1MQ (5-Amino-1-Methyl-Quinolinium) is a Small molecule NNMT inhibitor. Synthetic compound designed to inhibit nicotinamide N-methyltransferase (NNMT) and boost NAD+ synthesis through the salvage pathway. It is researched for fat oxidation, metabolic flexibility, improved grip strength, increased endurance, reduced muscle recovery time, anti-aging effects.
What is the recommended 5-Amino-1MQ dosage?
Common dosages: 150-500 mcg subcutaneous, 50-100 mg oral administered once to twice daily via subcutaneous injection or oral. Cycle length: 4-12 weeks. Half-life: not established in humans. Use our peptide calculator for exact reconstitution math.
What are the side effects of 5-Amino-1MQ?
Good tolerability in preclinical data. No major adverse events reported. Limited human safety data — long-term effects in humans unknown.
Is 5-Amino-1MQ safe?
5-Amino-1MQ has shown a preliminary safety profile in research. Not FDA-approved. Available as research chemical. Not scheduled or controlled. All research should follow appropriate safety protocols.